Women's exposure to second-hand smoke: a serious health concern
China eliminates maternal and neonatal tetanus
Regional Director Shin praises China's commitment to health
Statement from Dr Michael O'Leary, WHO Representative in China, for the launch of the Western Area Health Initiative
China Health Minister receives award for tobacco control from Director General of World Health Organization
China: Another milestone achieved towards regaining polio-free status
WHO applauds the Ministry of Health on the "China Report on the Health Hazards of Smoking"
Healthy Ageing in China
World TB Day: Stop TB in Your Lifetime!
WHO supports increasing prices for tobacco in China
Bolstering collaboration to support Member States and achieve the Sustainable Development Goals
Partnership, protection, response and empowerment: rolling out essential services to end gender-based violence against women and girls in Asia and the Pacific
Countries race against the clock to overcome antimicrobial resistance (AMR)
WHO stresses the importance of neonatal best practices for a healthy start to life
WHO Regional Committee for the Western Pacific notes progress on healthy newborn infants, antimicrobial resistance and essential medicines
Le Comité régional de l’OMS pour le Pacifique occidental prend acte des progrès accomplis pour ce qui est de la santé des nouveau-nés, de la résistance aux antimicrobiens et des médicaments essentiels
WHO's work in countries in the Western Pacific Region
Achieving the Sustainable Development Goals: Member States commit to leave no one behind
Sur la voie de la réalisation des objectifs de développement durable : les États Membres s’engagent à ne laisser personne de côté
Strengthening domestic financing: a key to addressing priority public health programmes
Message by the WHO Director-General to the people of Tenerife regarding the hantavirus response
New evidence confirms malaria vaccine saves child lives and will have high impact in wider rollout
WHO’s response to hantavirus cases linked to a cruise ship
Medical Product Alert N°1/2026: Substandard ACCUPAQUE (Iohexol), OMNIPAQUE (Iohexol) and VISIPAQUE (Iodixanol)